{
    "symbol": "HUMA",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-13 14:21:34",
    "content": " Please proceed with your questions. Please proceed with your questions. And so part of that effort was and we learned part of that in our clinical studies, but part of that is taking advantage of the great database of patients on a non-name basis that\u2019s available through the Fresenius network, and trying to identify those patients that have the biggest unmet needs. We have a number of programs that are ongoing, but again, many, or most companies at our stage of development really don\u2019t have access to this kind of very granular data around cost of care and issues with care for patients who are in one of our target therapeutic areas. Please proceed with your questions. Please proceed with your questions."
}